Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

NCT05885009 · clinicaltrials.gov ↗

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

GENETIC: Liquid Biopsy
GENETIC: Archival Tumor DNA sequencing

Sponsor

SOLTI Breast Cancer Research Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]